Routine cognitive screening in Parkinson disease (PD) has become essential for management, to track progression and to assess clinical status in therapeutic trials. Patients with mild cognitive impairment (PD-MCI) are more likely to progress to dementia and therefore need to be distinguished from patients with normal cognition and those with dementia. A three-class Youden index has been recently proposed to select cut-off points in three-class classification problems. In this article, we examine properties of a modification of the three-class Youden index and propose a generalization to k-class classification problems. Geometric and theoretical properties of the modified index Jk are examined. It is shown that Jk is equivalent to the sum of...
Objective: To identify cognitive phenotypes within Parkinson’s disease (PD) and compare them to the ...
Cognitive impairment is common in Parkinson\u27s disease (PD). There is a critical need for a brief,...
International audienceBACKGROUND: Clinical presentation and progression of cognitive disorders in Pa...
Cognitive impairment is one of the earliest, most common, and most disabling non-motor symptoms in P...
Introduction: Clinical presentation and progression of cognitive disorders in Parkinson's disease (P...
IntroductionCognitive impairment is a common complication of Parkinson's disease (PD) and identifyin...
Clinical impression of severity index (CISI) for Parkinson's disease (PD) is an index to assess PD s...
Screening of global cognitive performance is of great importance in the detection of early cognitive...
Dementia in Parkinson's disease (PD) is a serious health issue and a major concern for many patients...
The objective of this study was to identify different cognitive phenotypes in Parkinson's disease (P...
Dementia in Parkinson's disease (PD) is a serious health issue and a major concern for many patients...
Mild cognitive impairment has gained recognition as a construct and a potential prodromal stage to d...
Given the high prevalence of cognitive impairment in Parkinson's disease (PD), cognitive screening i...
Introduction The early diagnosis of mild cognitive impairment (PD-MCI) in Parkinson's disease (PD) i...
Background: Dementia is a new focus of research on improved treatment for Parkinson's disease (PD). ...
Objective: To identify cognitive phenotypes within Parkinson’s disease (PD) and compare them to the ...
Cognitive impairment is common in Parkinson\u27s disease (PD). There is a critical need for a brief,...
International audienceBACKGROUND: Clinical presentation and progression of cognitive disorders in Pa...
Cognitive impairment is one of the earliest, most common, and most disabling non-motor symptoms in P...
Introduction: Clinical presentation and progression of cognitive disorders in Parkinson's disease (P...
IntroductionCognitive impairment is a common complication of Parkinson's disease (PD) and identifyin...
Clinical impression of severity index (CISI) for Parkinson's disease (PD) is an index to assess PD s...
Screening of global cognitive performance is of great importance in the detection of early cognitive...
Dementia in Parkinson's disease (PD) is a serious health issue and a major concern for many patients...
The objective of this study was to identify different cognitive phenotypes in Parkinson's disease (P...
Dementia in Parkinson's disease (PD) is a serious health issue and a major concern for many patients...
Mild cognitive impairment has gained recognition as a construct and a potential prodromal stage to d...
Given the high prevalence of cognitive impairment in Parkinson's disease (PD), cognitive screening i...
Introduction The early diagnosis of mild cognitive impairment (PD-MCI) in Parkinson's disease (PD) i...
Background: Dementia is a new focus of research on improved treatment for Parkinson's disease (PD). ...
Objective: To identify cognitive phenotypes within Parkinson’s disease (PD) and compare them to the ...
Cognitive impairment is common in Parkinson\u27s disease (PD). There is a critical need for a brief,...
International audienceBACKGROUND: Clinical presentation and progression of cognitive disorders in Pa...